Stakeholder perspectives on the demand and supply factors driving substandard and falsified blood pressure lowering medications in Nigeria: a qualitative study

por Shedul, Grace, Sanuade, Olutobi Adekunle, Ugwuneji, Eugenia N, Ojo, Tunde M, Vijay, Aishwarya, Ponzing, Patrick, Okpe, Inuwa, Shedul, Gabriel Lamkur, Huffman, Mark D, Ojji, Dike, Hirschhorn, Lisa R
Publicado 2022

Characteristics and Patterns of Retention in Hypertension Care in Primary Care Settings From the Hypertension Treatment in Nigeria Program

por Ye, Jiancheng, Orji, Ikechukwu A., Baldridge, Abigail S., Ojo, Tunde M., Shedul, Grace, Ugwuneji, Eugenia N., Egenti, Nonye B., Aluka-Omitiran, Kasarachi, Okoli, Rosemary C. B., Eze, Helen, Nwankwo, Ada, Hirschhorn, Lisa R., Chopra, Aashima, Ale, Boni M., Shedul, Gabriel L., Tripathi, Priya, Kandula, Namratha R., Huffman, Mark D., Ojji, Dike B.
Publicado 2022

Fixed‐dose combination therapy‐based protocol compared with free pill combination protocol: Results of a cluster randomized trial

por Sanuade, Olutobi A., Ale, Boni M., Baldridge, Abigail S., Orji, Ikechukwu A., Shedul, Gabriel L., Ojo, Tunde M., Shedul, Grace, Ugwuneji, Eugenia N., Egenti, Nonye, Omitiran, Kasarachi, Okoli, Rosemary, Eze, Helen, Nwankwo, Ada, Hirschhorn, Lisa R., Chopra, Aashima, Ye, Jiancheng, Tripathi, Priya, Banigbe, Bolanle, Kandula, Namratha R., Huffman, Mark D., Ojji, Dike B.
Publicado 2023

Hypertension Treatment in Nigeria (HTN) Program: rationale and design for a type 2 hybrid, effectiveness, and implementation interrupted time series trial

por Baldridge, Abigail S., Aluka-Omitiran, Kasarachi, Orji, Ikechukwu A., Shedul, Gabriel L., Ojo, Tunde M., Eze, Helen, Shedul, Grace, Ugwuneji, Eugenia N., Egenti, Nonye B., Okoli, Rosemary C. B., Ale, Boni M., Nwankwo, Ada, Osagie, Samuel, Ye, Jiancheng, Chopra, Aashima, Sanuade, Olutobi A., Tripathi, Priya, Kandula, Namratha R., Hirschhorn, Lisa R., Huffman, Mark D., Ojji, Dike B.
Publicado 2022